Equipped with an ardent interest in writing, Ojaswita Kutepatil, a content developer by profession, presently writes articles for exsoft.org and a couple of other portals. When she isn’t harnessing the power of the pen, she loves to pursue her hobbies of cooking, reading, and crafting, to name a few. She can be contacted at- [email protected] | https://twitter.com/ojaswita_k
Pfizer has entered into an agreement with the investment firm Bain Capital, for spinning out its neuroscience portfolio into a joint venture. The two companies have created Cereval Therapeutics, after a funding of $350m (€306m) from Bain Capital, and Pfizer is holding a 25% stake …
Pfizer Inc. and Eli Lilly & Co. recently announced that a paid drug being developed by both of them has shown promising results in a large clinical trial for treating osteoarthritis. Osteoarthritis, for the uninitiated, is a chronic condition that affects joints, occurring mostly in …
The U.S. Food and Drug Administration has recently granted approval for new drug Xofluza (baloxavir marboxil) which would be used for treating flu. Reportedly, this is the first antiviral flu drug to be approved by FDA in almost 20 years. According to the reports, a …
Oracle Corporation has reportedly announced its second generation of cloud infrastructure solutions at the company’s yearly flagship event Oracle OpenWorld 2018 in San Francisco on Monday. As per trusted sources, the announcement had been made by the Chief Technology Officer and Executive Chairman of the …
Electric scooter startup Lime is reportedly opening a new ‘lifestyle brand store’ in Santa Monica. As per trusted sources, the firm will certainly rent scooters out of the storefront. However, the big idea behind the brick-and-mortar store is placing heavy importance over customer engagement and …
The European Commission has approved the $7.5 billion acquisition of GitHub by Microsoft, which is anticipated to be completed by the end of this calendar year. Speaking on the approval, the Commission stated that Microsoft would not have any incentive to undermine the open nature …
The entrectinib cancer pill from Roche was reportedly found to shrink tumors in 57 percent of patients, in a group which can be identified only through genetic profiling. The Swiss pharmaceutical giant supposedly aims to challenge the alliance of Bayer and Loxo Oncology in an …
United States-based cannabis company, MedMen Enterprises Inc. has recently announced signing of a definitive agreement to acquire Viktoriya’s Medical Supplies LLC dba Buddy’s Cannabis, a microbusiness license company entitling retail, distribute, cultivate and manufacturing of cannabis onsite in San Jose, California. Sources suggest that the …
